BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30666440)

  • 1. Correlation between the duration of locoregional control and survival in T1-T2 oropharyngeal cancer patients.
    Caula A; Boukhris M; Guerlain J; Tao Y; Breuskin I; Mirghani H; Temam S; Gorphe P
    Eur Arch Otorhinolaryngol; 2019 Apr; 276(4):1161-1166. PubMed ID: 30666440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of disease recurrence following treatment of oropharyngeal cancer with intensity modulated radiation therapy.
    Garden AS; Dong L; Morrison WH; Stugis EM; Glisson BS; Frank SJ; Beadle BM; Gunn GB; Schwartz DL; Kies MS; Weber RS; Ang KK; Rosenthal DI
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):941-7. PubMed ID: 22975604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissection: Association with locoregional recurrence, distant metastasis, and decreased survival.
    Sandulache VC; Ow TJ; Daram SP; Hamilton J; Skinner H; Bell D; Rosenthal DI; Beadle BM; Ang KK; Kies MS; Johnson FM; El-Naggar AK; Myers JN
    Head Neck; 2013 Oct; 35(10):1454-60. PubMed ID: 23018868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locoregional and distant recurrence for HPV-associated oropharyngeal cancer using AJCC 8 staging.
    Contrera KJ; Smile TD; Mahomva C; Wei W; Adelstein DJ; Broughman JR; Burkey BB; Geiger JL; Joshi NP; Ku JA; Lamarre ED; Lorenz RR; Prendes BL; Scharpf J; Schwartzman LM; Woody NM; Xiong D; Koyfman SA
    Oral Oncol; 2020 Dec; 111():105030. PubMed ID: 33038751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-category remains an important prognostic factor for oropharyngeal carcinoma in the era of human papillomavirus.
    Mackenzie P; Pryor D; Burmeister E; Foote M; Panizza B; Burmeister B; Porceddu S
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):643-7. PubMed ID: 25001635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T1-T2 NO oropharyngeal cancers treated with surgery alone. A GETTEC study.
    Cosmidis A; Rame JP; Dassonville O; Temam S; Massip F; Poissonnet G; Poupart M; Marandas P; De Raucourt D;
    Eur Arch Otorhinolaryngol; 2004 May; 261(5):276-81. PubMed ID: 14551793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of relapsed human papillomavirus-related oropharyngeal squamous cell carcinoma treated with curative intent.
    Pipkorn P; Sinha P; Kallogjeri D; Adkins D; Thorstad WT; Rich JT; Jackson RS
    Head Neck; 2019 May; 41(5):1312-1319. PubMed ID: 30536710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.
    Frakes JM; Naghavi AO; Demetriou SK; Strom TJ; Russell JS; Kish JA; McCaffrey JC; Otto KJ; Padhya TA; Harrison LB; Trotti AM; Caudell JJ
    Cancer; 2016 Feb; 122(4):634-41. PubMed ID: 26565997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
    Sims JR; Van Abel K; Martin EJ; Lohse CM; Price DL; Olsen KD; Moore EJ
    Otolaryngol Head Neck Surg; 2017 Jul; 157(1):69-76. PubMed ID: 28374634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
    Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
    Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.
    Zenga J; Jackson RS; Graboyes EM; Sinha P; Lindberg M; Martin EJ; Ma D; Thorstad WL; Rich JT; Moore EJ; Haughey BH
    Laryngoscope; 2017 Mar; 127(3):623-630. PubMed ID: 27634021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinoma.
    Liskamp CP; Janssens GO; Bussink J; Melchers WJ; Kaanders JH; Verhoef CG
    Head Neck; 2016 Dec; 38(12):1780-1787. PubMed ID: 27248701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between the time to locoregional recurrence and survival in laryngeal squamous-cell carcinoma.
    Gorphe P; Tao Y; Blanchard P; Even C; Moya-Plana A; Mirghani H; Nguyen F; Temam S; Janot F
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2267-2271. PubMed ID: 28185009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transoral robotic surgery for oropharyngeal carcinoma: Surgical margins and oncologic outcomes.
    Moore EJ; Van Abel KM; Price DL; Lohse CM; Olsen KD; Jackson RS; Martin EJ
    Head Neck; 2018 Apr; 40(4):747-755. PubMed ID: 29327784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage surgery for oropharyngeal squamous cell carcinomas: A retrospective study from 2005 to 2013.
    Philouze P; Péron J; Poupart M; Pujo K; Buiret G; Céruse P
    Head Neck; 2017 Sep; 39(9):1744-1750. PubMed ID: 28557145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volumetric
    Chotchutipan T; Rosen BS; Hawkins PG; Lee JY; Saripalli AL; Thakkar D; Eisbruch A; El Naqa I; Mierzwa ML
    Head Neck; 2019 Feb; 41(2):366-373. PubMed ID: 30548704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage treatment for recurrent oropharyngeal squamous cell carcinoma.
    Röösli C; Studer G; Stoeckli SJ
    Head Neck; 2010 Aug; 32(8):989-96. PubMed ID: 19953618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor volume as a prognostic factor in oropharyngeal squamous cell carcinoma treated with primary radiotherapy.
    Been MJ; Watkins J; Manz RM; Gentry LR; Leverson GE; Harari PM; Hartig GK
    Laryngoscope; 2008 Aug; 118(8):1377-82. PubMed ID: 18418275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.